€100 FOR FREE with Trading212‼️ 1) Register for an invest account using my link 2) Deposit a minimum of €1 before 10 days after registration and buy at least €1 of a stock you like 3) Collect your Free share worth up to €100 trading212.com/invite/4Dru0x… Let’s help each other 💪🏻

I put my money where my mouth is👇🏻 As I was telling you the best opportunities I see in the market are: $META $MSFT $CELH $AMZN $ELF $MA $NOW I’m loading up on those🫡 Someone with me?

Morning 🌅 Have a good Sunday 💪🏻 Someone of you did buy $SPCX ?

🚨 ROAD TO 100K, Weekly Update ‼️ 📊TOT VALUE: $35,227 📈PERFORMANCE: -1.11% 🟢 Best Weekly’s Performers: $ELF 22.8% $CELH 3.97% $NVO 3.93% 🔴 Worse Weekly’s Performers: $CRM -10.0% $NOW -8.51% $ZETA -7.67% FOLLOW TO SEE UPDATES ON MY BUYS AND SELLS🔥 How did perform your Portfolio this week?🔥

Someone could explain me why $NOW down 25% in 9 days?😅

Day 5 of posting $SOFI until hits $50 (Fair value🫢) NO DEBT AT ALL

🚨 TRADE ALERT 🚨 I want to share this trade I’m still in. Bought on the third touch of the daily level and let it run 🚀 🟢 I’m already up 41.2% 😬 SL on the most recent low at 0.7600 If you want me to see similar trades don’t forget to follow 🔥

Do you think $SOFI is a BUY NOW? During the last 5 Years: Revenue: 376% EPS: Turned positive Price: -24.55% 🔴 I think something is wrong here🤔

🚨 THIS STOCK COULD 10X BY 2030 🚨 Adaptive Biotechnologies $ADPT Here is my buy thesis and why it has multibagger potential over the next few years. 1️⃣ BUY THESIS Adaptive's economic engine is clonoSEQ-an FDA-cleared measurable residual disease (MRD) test for blood cancers (like leukemia and multiple myeloma). It is rapidly becoming the gold standard in oncology. — Massive Growth: The MRD segment is on fire, up 53% YoY in early 2026, and now accounts for 95% of total revenue. — Deep Moat: The test is highly integrated into Electronic Medical Records (EMRs), making it incredibly sticky for healthcare providers. — Derisked Pipeline: Unlike speculative, pre-revenue biotechs, $ADPT has a proven commercial product that is already generating hundreds of millions. 2️⃣ WHY IT’S A 10X BY 2030: To pull off a 10X return, a company needs a massive Total Addressable Market (TAM) and serious operating leverage. Here is how $ADPT gets there: — Flipping the Profitability Switch: The company is targeting positive adjusted EBITDA in 2025 and positive Free Cash Flow by the end of 2026. Once a commercial-stage biotech scales past its cash burn, valuation multiples tend to expand violently. — TAM Expansion: Right now, clonoSEQ dominates specific blood cancers. Expanding into broader oncology and immune-medicine applications opens up a multi-billion dollar market. — Operating Leverage: As revenue (currently growing at ~35% overall) outpaces operating expenses, the bottom line will swell. If they maintain their high double-digit growth rate through the decade, a 10X valuation shift is entirely plausible. @HunterAllen4 I know you would like this one😉

🚨 $META STOCK ANALYSIS 🚨 Out stock analysis in my Substack page! Go check it💪🏻 open.substack.com/pub/lukesi…

Gm family🫡 Have a good weekend

Day 3 of posting $SOFI until hits $50 (Fair value🫢) EPS Price chart

🚨 ROAD TO 100K DAILY UPDATE 🚨 Tot Value: $35,208 Luke Portfolio: ⬆️ 0.15% S&P500: ⬆️ 0.54% Nasdaq: ⬆️ 0.59% Aggregated: ⬆️ 0.08% 🟢 Best performers: $CELH 2.75% $ACN 1.65% $VICI 1.53% 🔴 Worst performers: $RBRK -4.56% $ZTS -2.25% $PGY -2.10% BUYS: $META $MSFT $CELH FOLLOW TO DON’T MISS NEW BUYS 🔥 💰 Track my Full portfolio and live trades in the link in BIO $META $MA $MSFT $AMZN $CRM $ZETA $ADP $INTU $SPGI $NOW $ACN $VICI $CELH $UNH $NVO $RBRK $O $GOOGL $PGY $REXR $ELF $ZTS $TSM

Day 4 of posting $SOFI until hits $50 (Fair value🫢) Revenue Net Income chart

Do you think $MU is still a BUY ❓ Someone would say it’s Overvalued here🤔

"It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price." - Warren Buffet $NVDA & $MU Which one is the wonderful company?😬

Which stocks should I BUY/ ADD TO considering my Portfolio? $META $MA $MSFT $AMZN $CRM $ZETA $ADP $INTU $SPGI $NOW $ACN $VICI $CELH $UNH $NVO $RBRK $O $GOOGL $PGY $REXR $ELF $ZTS $TSM